Investigating suspected pulmonary embolism in pregnancyBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39071.617257.80 (Published 22 February 2007) Cite this as: BMJ 2007;334:418
- Andrew Frederick Scarsbrook, consultant radiologist and nuclear medicine physician1,
- Fergus Vincent Gleeson, consultant thoracic radiologist2
- 1Department of Radiology, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF
- 2Radiology Department, Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust, Headington, Oxford OX3 7LJ
- Correspondence to: F Gleeson
- Accepted 12 December 2006
A woman in her early 30s presented at 25 weeks' gestation with shortness of breath and chest pain. Clinical examination was unremarkable. The patient was referred for imaging to exclude suspected pulmonary embolism, as this potentially fatal disorder increases in incidence during pregnancy and is a leading cause of maternal mortality. Physiological changes in pregnancy often cause symptoms that mimic pulmonary embolic disease, such as chest pain and shortness of breath. Objective symptom scoring for assessing the pre-test probability is therefore less reliable in pregnancy and is used only rarely.
Physiological changes during pregnancy can mimic pulmonary embolism, making clinical diagnosis unreliable
Imaging is essential to avoid inappropriate treatment and can be performed without exposing the fetus to any specific risks
A chest x ray should always be performed to exclude other causes
Half dose perfusion scintigraphy can be used in most patients
Computed tomographic pulmonary angiography should be used only in patients with lung disease such as asthma—which makes scintigraphy less likely to be diagnostic—or an abnormal chest x ray, because it exposes maternal breast tissue to high doses of radiation
What test do I order?
Venous thromboembolism is an important diagnosis to confirm or refute, as the risks of inappropriate use of anticoagulants or missing a pulmonary embolism far outweigh the risks associated with exposing mother and fetus to ionising radiation. In pregnant patients with suspected pulmonary embolism who are acutely and seriously ill, a portable echocardiogram should be the initial test to detect pulmonary embolism if expertise is readily available. In all other pregnant patients, chest radiography should be the first line imaging investigation.
Chest x ray—This is required to exclude a chest infection or pneumothorax.
Compression ultrasonography of the lower limb—Ultrasonography is required to exclude deep vein thrombosis. Although this has a low diagnostic yield, it does not expose the mother or fetus to any risk and, if positive, allows appropriate treatment.
If the ultrasound is negative, the chest x ray is normal, and the patient has no history of lung disease including asthma, a half dose lung perfusion scintigram should be performed. Alternatively, if the patient has lung disease or the chest x ray is abnormal (and a suspicion of pulmonary embolism remains) a computed tomographic pulmonary angiogram should be performed.
Radionuclide lung scintigraphy—This test has a high negative predictive value and has been carefully evaluated in a prospective case series of pregnant women (n=120) with suspected pulmonary embolism.1 The incidence of non-diagnostic scans is high in non-pregnant patients, mainly as a result of chronic lung disease. However, pregnant patients are generally younger and less likely to have abnormal lungs. Non-diagnostic scans can be minimised by triaging patients with an abnormal chest radiograph to computed tomographic pulmonary angiography.2 Fetal radiation exposure is higher with scintigraphy (0.11-0.22 mGy) than with computed tomographic pulmonary angiography (0.01-0.06 mGy), but it is well below the threshold for any specific risks.3 The only theoretical risk from in utero radiation exposures of less than 50 mGy is induction of malignancy.4 The estimated incidence of childhood malignancy after in utero exposure is about one in 16 000 per mGy.5 To minimise fetal radiation exposure, half dose perfusion scintigraphy is performed as standard practice during pregnancy, with no loss in diagnostic accuracy.
Computed tomographic pulmonary angiography—This is the gold standard diagnostic test in non-pregnant patients with suspected pulmonary embolism, but its use in pregnancy has not been validated. For example, a large multicentre prospective trial (n=824) to assess the efficacy of this test in patients with suspected pulmonary embolism formally excluded pregnant women.6 Importantly, this test exposes mothers to high doses of radiation. Estimated exposure of maternal breast tissue is up to 35 mGy per breast.7 The latent carcinogenic effects of radiation exposure are uncertain, but radiosensitive, proliferating, breast tissue is likely to be at increased risk. The lifetime risk of breast carcinoma has been reported to increase after a single 10 mGy dose of radiation to the breast in women under 35 years.89 The estimated exposure of breast tissue to radiation from half dose perfusion scintigraphy is several magnitudes smaller (0.25 mGy) than that from computed tomography pulmonary angiography.10 In addition, during computed tomography pulmonary angiography both the mother and fetus are exposed to intravenous iodinated contrast medium. Data on the risks associated with this exposure are limited, but neonatal hypothyroidism should be excluded postnatally if this test has been performed during pregnancy.11
Pulmonary angiography—Although this test was considered the gold standard against which other imaging techniques were compared, it is now thought to be no more accurate than well performed computed tomographic pulmonary angiography. The technique is invasive and is associated with a significantly higher radiation dose than CTPA. For these reasons it has a limited role in evaluating patients with suspected pulmonary embolism, especially those who are pregnant.
Scarsbrook AF, Evans AL, Owen AR, Gleeson FV. Diagnosis of suspected venous thromboembolic disease in pregnancy. Clin Radiol 2006;61:1-12
Our patient had no history of lung disease, a normal chest x ray, and negative lower limb ultrasonography. She therefore underwent half dose perfusion scintigraphy, which was normal (figure⇓). Her symptoms resolved spontaneously and the remainder of her pregnancy was uncomplicated.
This series provides an update on the best use of different imaging methods for common or important clinical presentations. The series editors are Fergus Gleeson, consultant radiologist, Churchill Hospital, Oxford, and Kamini Patel, consultant radiologist, Homerton University Hospital, London
Contributors: FVG had the original idea. AFS selected the patient, searched the literature, and wrote the paper. FVG reviewed and edited the paper and reanalysed the literature. FVG is guarantor.
Competing interests: None declared.